Pharmaceutical Executive Daily: Wegovy Pill Becomes Available

Jan 05, 07:28 PM

Headliner
Share
Subscribe

In today’s Pharmaceutical Executive Daily, the Wegovy Pill becomes the first available oral GLP-1 for weight management, clears a new therapy to prevent motion-induced vomiting, and Sanofi enters a new antibody discovery collaboration targeting autoimmune disease.

Share
Subscribe
Next
Pharmaceutical Executive Daily: Alnylam Invests $250 Million in Manufacturing Facility
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
by Pharmaceutical Executive